Putnam Investments’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$386K Sell
10,628
-1,361
-11% -$44.6K ﹤0.01% 1020
2023
Q3
$385K Buy
+11,989
New +$407K ﹤0.01% 977
2022
Q2
Sell
-7,055
Closed -$320K 1215
2022
Q1
$320K Sell
7,055
-527
-7% -$23.1K ﹤0.01% 1112
2021
Q4
$365K Buy
+7,582
New +$382K ﹤0.01% 1077

Other funds holding SRDX

Putnam Investments's SRDX Position: Q4 2023 in Review

Putnam Investments reduced its Surmodics (SRDX) stake by 11% in Q4 2023, selling an estimated $44.6K and leaving 10,628 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Putnam Investments first reported a position in SRDX in Q4 2021 and has held it in 4 quarters since. 117 funds tracked by Wall St. Rank hold SRDX as of Q4 2023.

  • Putnam Investments held 10,628 shares of Surmodics worth $386K as of Q4 2023.
  • Putnam Investments sold 1,361 Surmodics shares in Q4 2023, an estimated $44.6K.
  • Surmodics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1020 holding.
  • Putnam Investments first reported a position in Surmodics in Q4 2021 and has held it in 4 quarters since.
  • 117 funds tracked by Wall St. Rank held Surmodics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.